\u767e\u6fdf\u795e\u5dde\uff08NASDAQ\uff1aBGNE\uff09<\/a>\u548c\u764c\u75c7\u5408\u4f5c\u5925\u4f34\u5b89\u9032\uff08NASDAQ\uff1aAMGN\uff09<\/a>\u8868\u793a\uff0c\u7531\u65bc\u884c\u4f7f\u671f\u6b0a\u548c\u9650\u5236\u6027\u80a1\u7968\u55ae\u4f4d\u800c\u5c0e\u81f4\u6d41\u901a\u80a1\u6578\u91cf\u589e\u52a0\uff0c\u6240\u4ee5\u540c\u610f\u767e\u6fdf\u795e\u5dde\u540c\u610f\u5b89\u9032\u64c1\u6709\u66f4\u591a\u80a1\u4efd\uff0c\u4f7f\u5b89\u9032\u4fdd\u630120.5%\u7684\u80a1\u6b0a\u6bd4\u4f8b\u3002<\/p>\n \u5728\u4e00\u4efd\u8072\u660e\u4e2d\uff0cAlexion Pharmaceuticals\uff08NASDAQ\uff1aALXN\uff09<\/a>\u8aaa\uff0c\u5b83\u5df2\u7d93\u5efa\u7acb\u4e86\u201c\u5805\u5be6\u7684\u57fa\u790e\u201d\u4f86\u63a8\u52d5\u589e\u9577\u4e26\u63d0\u9ad8\u80a1\u6771\u50f9\u503c\uff0c\u4e26\u4e14\u4e0d\u6253\u7b97\u6309\u7167\u80a1\u6771Elliott Advisors\u7684\u63d0\u8b70\u9032\u884c\u76f4\u63a5\u51fa\u552e\u3002<\/p>\n \u7ba1\u7406\u5c64\u5f15\u7528\u5b8c\u5584\u7684\u7b56\u7565\uff0c\u5c07\u73fe\u6709\u8cc7\u7522\u64f4\u5c55\u5230\u65b0\u75be\u75c5\u4e2d\uff0c\u4e26\u6539\u9032\u4e86\u7522\u54c1\u7dda\u3002\u8a72\u516c\u53f8\u80a1\u50f9\u4e0a\u6f32\u4e866%\u3002<\/p>\n Gemphire Therapeutics\uff08NASDAQ\uff1aGEMP\uff09<\/a>\u7684\u80a1\u6771\u5df2\u6279\u51c6\u6240\u6709\u8207NeuroBo\u5408\u4f75\u76f8\u95dc\u7684\u63d0\u8b70\uff0c\u5305\u62ec\uff1a\uff08i\uff09\u6839\u64da7\u670824\u65e5\u7684\u5354\u8b70\u767c\u884cGemphire\u666e\u901a\u80a1\uff0c\uff08ii\uff09Gemphire\u666e\u901a\u80a1\u7684\u53cd\u5411\u80a1\u7968\u5206\u5272\uff1b\u4e26\u4e14\uff08iii\uff09\u5c07\u540d\u7a31\u5f9e\u201c Gemphire Therapeutics\u201d\u66f4\u6539\u70ba\u201c NeuroBo Pharmaceuticals\uff0cInc.\u201d<\/p>\n \u4ea4\u6613\u5b8c\u6210\u5f8c\uff0c\u516c\u53f8\u80a1\u7968\u6709\u671b\u5728\u7d0d\u65af\u9054\u514b\u958b\u59cb\u4ea4\u6613\uff0c\u80a1\u7968\u4ee3\u78bc\u70ba\u201c NRBO\u201d\u3002<\/p>\n FDA\u5c07\u5f37\u751f\u516c\u53f8\uff08NYSE\uff1aJNJ\uff09<\/a>\u65d7\u4e0b\u694a\u68ee\u88fd\u85e5\u7684CAR T\u5019\u9078\u85e5\u7269JNJ-682284528\uff08JNJ-4528\uff09\u6307\u5b9a\u70ba\u6cbb\u7642\u5fa9\u767c\/\u96e3\u6cbb\u6027\u591a\u767c\u6027\u9aa8\u9ad3\u7624\u7684\u7a81\u7834\u6027\u7642\u6cd5\u3002<\/p>\n \u7a81\u7834\u6027\u6cbb\u7642\u72c0\u614b\u70baFDA\u63d0\u4f9b\u4e86\u95dc\u65bc\u958b\u767c\u7684\u66f4\u6df1\u5165\u7684\u6307\u5c0e\uff0c\u66f4\u591a\u9ad8\u7d1a\u6a5f\u69cb\u4eba\u54e1\u7684\u53c3\u8207\u4ee5\u53ca\u5c0d\u71df\u92b7\u7533\u8acb\u7684\u52a0\u901f\u5be9\u67e5\u3002<\/p>\n bluebird bio\uff08NASDAQ\uff1aBLUE\uff09<\/a>\u548c\u88ab\u8a31\u53ef\u65b9\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6\uff08NYSE\uff1aBMY\uff09<\/a>\u5ba3\u4f48\u4e86\u4e00\u98052\u671f\u81e8\u5e8a\u8a66\u9a57KarMMa\u7684\u7a4d\u6975\u7d50\u679c\uff0c\u8a72\u7d50\u679c\u8a55\u4f30\u4e86CAR T\u7642\u6cd5bb2121\u5c0d\u8010\u591a\u85e5\u9aa8\u9ad3\u7624\uff08MM\uff09\u60a3\u8005\u7684\u7642\u6548\u3002<\/p>\n \u8a72\u7814\u7a76\u7b26\u5408\u4e3b\u8981\u548c\u4e3b\u8981\u6b21\u8981\u7d42\u9ede\u3002\u5177\u9ad4\u800c\u8a00\uff0c\u4e09\u5291\uff08\u4e3b\u8981\u7d42\u9ede\uff09\u7684\u7e3d\u7de9\u89e3\u7387\uff08ORR\uff09\u70ba73.4%\uff08n = 94\/128\uff09\u3002\u7de9\u89e3\u7387\u8207\u5291\u91cf\u6709\u95dc\uff0c\u70ba50.0%\uff08n = 2\/4\uff09\u6700\u4f4e\uff0c\u4e2d\u9593\u70ba68.6%\uff08n = 48\/70\uff09\uff0c\u6700\u9ad8\u70ba81.5%\uff08n = 44\/54\uff09\u3002\u5b8c\u5168\u56de\u61c9\u7387\u5206\u5225\u70ba25%\u300128.6%\u548c35.2%\u3002 \u5169\u5bb6\u516c\u53f8\u80a1\u50f9\u5747\u4e0a\u6f321%\u3002<\/p>\n","protected":false},"excerpt":{"rendered":" Citing an increase in the number of outstanding shares due to option exercises and vesting of restricted share units, BeiGene (NASDAQ:BGNE) and cancer collaboration partner Amgen (NASDAQ:AMGN) have agreed to increase the number of shares allowable to the latter in order for it to maintain its 20.5% stake.<\/p>\n","protected":false},"author":9,"featured_media":308816,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,644],"class_list":["post-308823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-644","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/308823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=308823"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/308823\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/308816"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=308823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=308823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=308823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Alexion\u5c0d\u73fe\u72c0\u5145\u6eff\u4fe1\u5fc3\uff0c\u672a\u8a08\u5283\u51fa\u552e<\/h2>\n
Gemphire\u7684\u80a1\u6771\u6279\u51c6NeuroBo\u5408\u4f75\u63d0\u6848<\/h2>\n
FDA\u52a0\u901f\u5be9\u67e5\u5f37\u751fCAR T\u85e5\u7269<\/h2>\n
\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6\u548cbluebird bio\u7684CAR T\u7642\u6cd5\u53d6\u5f97\u6210\u529f<\/h2>\n
\n\u4e2d\u4f4d\u53cd\u61c9\u6301\u7e8c\u6642\u9593\u70ba10.6\u500b\u6708\uff0c\u4e2d\u4f4d\u7121\u9032\u5c55\u751f\u5b58\u671f\u70ba8.6\u500b\u6708\u3002<\/p>\n